In this manuscript, we explored the association between the expression levels of RBM43 with clinicopathological characteristics and overall prognosis for the first time, using immunohistochemistry (IHC) in 207 pairs of ESCC tissues and adjacent non-tumor tissues from Sun Yat-sen University Cancer Center (SYSUCC). Here, RBM43 is linked to neoplasm.